A 67-year-old man comes to the emergency department complaining of progressive shortness o… — USMLE Step 2 CK

A 67-year-old man comes to the emergency department complaining of progressive shortness of breath, increased cough, and yellow sputum production over the past 48 hours. He has a 45-pack-year smoking history and severe chronic obstructive pulmonary disease (COPD). His temperature is 38.2°C, blood pressure is 140/85 mm Hg, pulse is 112/min, and respirations are 26/min. Pulse oximetry shows an oxygen saturation of 88% on room air. He is using accessory muscles of respiration. Physical examination reveals an expanded barrel chest, diffuse expiratory wheezing bilaterally, and coarse crackles over the left lower lung base. Jugular venous pressure is 7 cm $H_2O$ . A chest radiograph demonstrates hyperinflated lung fields, flattened diaphragms, and a new consolidation in the left lower lobe. Sputum Gram stain shows numerous polymorphonuclear leukocytes and frequent Gram-positive diplococci. Arterial blood gas analysis on room air reveals:

Parameter	Value
pH	7.30
$PaCO_2$	60 mm Hg
$PaO_2$	54 mm Hg
$HCO_3^-$	29 mEq/L

Which of the following are the most appropriate next steps in the management of this patient? (Select all that apply)

Initiate noninvasive positive-pressure ventilationAnswer
Administer systemic glucocorticoids and short-acting inhaled bronchodilatorsAnswer
C
Administer intravenous furosemide
D
Initiate empiric intravenous meropenem and vancomycin
E
Calculate expected $PaCO_2$ using Winter's formula

Answer

The most appropriate immediate steps are to initiate noninvasive positive-pressure ventilation and to administer systemic glucocorticoids along with short-acting inhaled bronchodilators.

The patient is experiencing a severe exacerbation of COPD triggered by community-acquired pneumonia, which has led to acute-on-chronic hypercapnic respiratory failure. The arterial blood gas demonstrates a primary respiratory acidosis with a pH of 7.30 and a

PaCO_2

of 60 mm Hg. In patients with a COPD exacerbation, noninvasive positive-pressure ventilation (NPPV) is strongly indicated when the pH is less than 7.35, as it decreases mortality, reduces the rate of endotracheal intubation, and improves respiratory acidosis. Alongside ventilatory support, standard medical management includes systemic glucocorticoids and short-acting inhaled bronchodilators (e.g., albuterol and ipratropium) to reduce airway inflammation and promote bronchodilation. Targeted antibiotic therapy is also indicated, but it must be tailored to the likely pathogens rather than broadly applying maximum coverage.

Step-by-Step Solution

Analyze the clinical presentation and physical examination.

The patient has a history of COPD and presents with fever, productive cough, focal crackles, and an acute worsening of dyspnea, indicating a COPD exacerbation triggered by community-acquired pneumonia.

Identifying the underlying triggers and primary pathology is essential to guide appropriate targeted therapy.

Interpret the arterial blood gas results.

The ABG shows an acidemia (pH 7.30) driven by hypercapnia (

PaCO_2

60 mm Hg), establishing a diagnosis of acute-on-chronic hypercapnic respiratory failure (respiratory acidosis).

Blood gas interpretation is critical for determining the severity of the exacerbation and the need for ventilatory support.

Select the appropriate evidence-based interventions.

Noninvasive positive-pressure ventilation (NPPV) is indicated due to the respiratory acidosis (pH < 7.35). Additionally, standard pharmacological therapy including systemic glucocorticoids, short-acting bronchodilators, and appropriately targeted antibiotics should be initiated.

NPPV reduces mortality and the need for intubation in severe COPD exacerbations, while bronchodilators and steroids treat the underlying airway obstruction and inflammation.

Key Concept

Management of acute exacerbations of COPD complicated by hypercapnic respiratory failure requires the initiation of noninvasive positive-pressure ventilation (if pH < 7.35) alongside systemic glucocorticoids, short-acting bronchodilators, and targeted antibiotic therapy.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic